2086178-00-7 (Vemircopan,Vemircopan)

Vemircopan;HN6I4K50QB;Vemircopan [INN];BDBM386545;US10287301, Compound 485;(1R,3S,5R)-2-(2- (3-acetyl-5-(2- methylpyrimidin- 5-yl)-1H-indazol- 1-yl)acetyl)-N-(6- bromo-3- methylpyridin-2- yl)-5-methyl-2- azabicyclo[3.1.0] hexane-3- carboxamide;(1R,3S,5R)-2-(2-(3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo(3.1.0)hexane-3-carboxamide;(1R,3S,5R)-2-[2-[;CFD-IN-1;ALXN2050;(1R,3S,5R)-2-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide;DA-68554;MS-30630;UNII-HN6I4K50QB;AKOS040757250;CHEMBL4650325;D12481;ALXN 2050;Factor D Inhibitor ALXN2050;G18523;VEMIRCOPAN [USAN];GLXC-25930;2-Azabicyclo[3.1.0]hexane-3-carboxamide, 2-[2-[3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl]acetyl]-N-(6-bromo-3-methyl-2-pyridinyl)-5-methyl-, (1R,3S,5R)-;(1R,3S,5R)-2-{[3-acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl]acetyl}-N-(6-bromo-3-methylpyridin-2-yl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxamide;ACH 5228;ACH0145228;ACH 0145228;CS-0213583;ACH-0145228;FD Inhibitor ALXN2050;Vemircopan (USAN/INN);ACH5228;2-Azabicyclo(3.1.0)hexane-3-carboxamide, 2-(2-(3-acetyl-5-(2-methyl-5-pyrimidinyl)-1H-indazol-1-yl)acetyl)-N-(6-bromo-3-methyl-2-pyridinyl)-5-methyl-, (1R,3S,5R)-;SCHEMBL18578125;ALXN2050; ACH 0145228; ACH-5228;2086178-00-7;ALXN-2050;ACH-5228;

OCXAGXCMZACNEC-CTWZREHQSA-N

1S/C29H28BrN7O3/c1-15-5-8-24(30)33-27(15)34-28(40)22-10-29(4)11-23(29)37(22)25(39)14-36-21-7-6-18(19-12-31-17(3)32-13-19)9-20(21)26(35-36)16(2)38/h5-9,12-13,22-23H,10-11,14H2,1-4H3,(H,33,34,40)/t22-,23+,29-/m0/s1

BrC1C([H])=C([H])C(C([H])([H])[H])=C(N=1)N([H])C([C@]1([H])C([H])([H])[C@@]2(C([H])([H])[H])C([H])([H])[C@@]2([H])N1C(C([H])([H])N1C2C([H])=C([H])C(C3=C([H])N=C(C([H])([H])[H])N=C3[H])=C([H])C=2C(C(C([H])([H])[H])=O)=N1)=O)=O